Jan Nolta Selected Research

Jan Nolta Research Topics

2	Neoplasms (Cancer) 09/2017 - 10/2016
2	Leukemia 10/2016 - 01/2008
1	Crohn Disease (Crohn's Disease) 01/2022
1	Fistula 01/2022
1	Disease Progression 01/2021
1	Neuroinflammatory Diseases 01/2021
1	Huntington Disease (Huntington's Disease) 01/2021
1	Hemophilia A (Haemophilia) 01/2019
1	Neuroblastoma 09/2017
1	Long Term Adverse Effects 09/2017
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2016
1	Medulloblastoma 04/2015
1	Inflammation (Inflammations) 12/2014
1	Retinitis Pigmentosa (Pigmentary Retinopathy) 12/2014
1	Macular Degeneration (Age-Related Maculopathy) 12/2014
1	Chondrosarcoma 11/2012
1	Fragile X Tremor Ataxia Syndrome 09/2012
1	Heart Failure 05/2012
1	Hepatocellular Carcinoma (Hepatoma) 10/2011
1	Sleep Initiation and Maintenance Disorders (Insomnia) 12/2010
1	Mucopolysaccharidosis VII (Sly Syndrome) 06/2009

3	Transcription Factors (Transcription Factor)IBA 09/2017 - 04/2015
2	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2017 - 11/2012
2	Small Interfering RNA (siRNA)IBA 09/2017 - 11/2012
2	Proteins (Proteins, Gene)FDA Link 09/2017 - 10/2016
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	Factor VIII (Coagulation Factor VIII)IBA 01/2019
1	Cisplatin (Platino)FDA LinkGeneric 09/2017
1	maphosphamideIBA 09/2017
1	Vincristine (Oncovin)FDA LinkGeneric 09/2017
1	Monoclonal AntibodiesIBA 10/2016
1	Antisense OligonucleotidesIBA 10/2016
1	Retinaldehyde (Retinal)IBA 12/2014
1	Aldehyde DehydrogenaseIBA 10/2011
1	Epithelial Cell Adhesion MoleculeIBA 10/2011
1	SolventsIBA 12/2010
1	Plant Preparations (Preparation, Plant)IBA 12/2010
1	GlucuronidaseIBA 06/2009

7	Therapeutics 01/2022 - 05/2012
2	Transplantation 01/2021 - 01/2019
1	Ileostomy 01/2022
1	Colostomy 01/2022
1	Drug Therapy (Chemotherapy) 09/2017
1	Hematopoietic Stem Cell Transplantation 01/2008